Cerebral aspergillosis, including infection of the sinuses is a serious infection and difficult to diagnose because it is usually misdiagnosed as tumor and is associated with high mortality.[@ref1],[@ref2] Surgical exploration and intra-operative diagnosis is required for accurate diagnosis and is made by histopathological examination.[@ref2] Early surgical intervention and aggressive antifungal treatment are considered as cornerstone management strategies.[@ref2] Aspergillosis of the sinuses is a spectrum of diseases that range from local infection involving the sinuses to invasive aspergillosis with extension to the brain and orbit.[@ref3],[@ref4] Invasive aspergillosis affects primarily immunocompromised hosts and rarely immunocompetent individuals.[@ref1]-[@ref7] Causes of Immunosuppression such as hematological malignancies, prolonged neutropenia and solid organ transplant are among the recognized risk factors for invasive aspergillosis.[@ref1]-[@ref6] Hematogenous dissemination of the infection to the brain or directly via the paranasal sinuses is associated with poor prognosis.[@ref3]-[@ref7] Cerebral abscess and ventriculitis caused by *Salmonella* species as a postoperative complication of craniotomy associated with fungal infection are extremely rare. This report presents the challenge of postoperative infectious complications in patients presenting with cerebral aspergillosis. It describes an unusual case of invasive aspergillosis of the paranasal sinuses involving the brain in a sickle cell disease (SCD) patient who eventually died because of post-craniotomy *Salmonella* ventriculitis, abscess collections and severe brain edema. The rapid clinical progression and complications of invasive sinusitis presented in this case highlight the importance of early diagnosis and initiation of antifungal treatment in such cases. This is a case report of invasive aspergillosis in a SCD patient from the Middle East region.

Case Report {#sec1-2}
===========

Patient information {#sec2-1}
-------------------

A 43-year-old female, a known case of SCD, presented to the Emergency room with a 2-month history of headache, dizziness, personality and behavioral changes, and recurrent vomiting.

Clinical findings {#sec2-2}
-----------------

Physical examination revealed an axillary temperature of 37.4°C; heart rate 156 bpm; respiratory rate 22 cpm; blood pressure 112/84 mmHg; and SpO~2~ 99%. She was examined by the ear, nose, and throat (ENT) specialist, and endoscopic evaluation of the sinuses suggested that the sinuses was the source of infection.

Diagnostic assessment {#sec2-3}
---------------------

Functional endoscopic sinus surgery was performed and endoscopic examination of the left nostril showed slough and dead tissue; pus was seen in the frontal sinus and the mucosa was unhealthy. During examination, she underwent debridement of the slough and dead tissue of the sphenoidal sinus, periorbita and septum mucosa. Local intranasal ceftriaxone and caspofungin were used during debridement of the sinuses. A brain computed tomography (CT) scan revealed a left frontal intra-axial thick-walled ring-enhancing lesion with extensive surrounding edema, possibly a high-grade neoplastic lesion (glioma) involving the corpus callosum, or a contiguous inflammatory or infectious process originating from the skull base. There were also bony and dural changes along the anterior skull base with erosion of the sella turcica and lateral sphenoid bone toward the cavernous sinus (**[Figure 1](#F1){ref-type="fig"}**). Initial clinical and radiological evaluation raised the suspicion of a brain tumor. Based on clinical examination, the decision was to perform a craniotomy and excisional biopsy of the frontal lobe lesion for diagnostic and therapeutic purposes. The risks associated with the surgery included infection, bleeding, recollection of abscesses, and recurrence. During surgery, a neuronavigation-guided frozen section of the brain lesion was performed which was sent to the histopathology laboratory. The intraoperative diagnosis was left granulomatous invasive fungal sinusitis with erosion of the sella turcica and lateral sphenoid bone toward the cavernous sinus. A granuloma was observed histologically and a few days later, cultures from the brain lesion and nasal tissue yielded many septate branching fungal hyphae identified as *Aspergillus flavus* (**[Figure 2](#F2){ref-type="fig"}**). The fungus was resistant to amphotericin B (minimum inhibitory concentration (MIC=2µg/mL), and susceptible to voriconazole (MIC=0.12µg/mL), itraconazole (MIC=0.12µg/mL) and posaconazole (MIC=0.06µg/mL). Aspergillus antigen test (galactomannan and IgG) yielded negative results. The final diagnoses, based on culture findings were invasive sinus aspergillosis and intracerebral aspergilloma.

![Post contrast administration MRI-Brain; **A**) Axial T1WI, A large mass lesion is noted in left frontal lobe, measuring about 6 x 5 cm. **B**) Axial T2WI, There is dural thickening and enhancement along the left cribriform plate, tuberculum sella and floor of sella. Mucosal thickening and abnormal density is noted in the sphenoid sinus and the left sphenoid sinus with well demarcated osseous defect on left side. **C**) Sagittal T1WI, bony and dural changes along the anterior skull base and left frontal intra-axial mass thick-walled ring enhancing lesion with extensive surrounding edema possibly aggressive neoplastic lesion, or less likely contiguous inflammatory or infectious process from skull base.](SaudiMedJ-39-935-g001){#F1}

![Photomicrograph of the brain lesion showing **A**) branched and septate fungal hyphae typical of aspergillosis in Grocott's methenamine silver stain. **B**) aspergillus flavus conidiophore bearing vesicle (phialides arise circumferentially from the globose vesicle) in Lactophenol cotton blue (LPCB).](SaudiMedJ-39-935-g002){#F2}

Therapeutic intervention {#sec2-4}
------------------------

Unfortunately, diagnostic endonasal sinus debridement was incomplete due to extensive infection that might spread to involve the cavernous sinus on aggressive management. Therefore, she underwent surgery (craniotomy) and repeated debridements were also carried out. Post-operatively, she tolerated the operation well, she was intubated and transferred to the surgical intensive care unit for observation and started on antifungal medication voriconazole (600 mg/day) and caspofungin (70 mg/day IV) and (50 mg/day IV) thereafter.

Follow up and outcomes {#sec2-5}
----------------------

She was afebrile, she had no basal discharge, she could move all limbs and was taking orally. Her Glasgow coma scale (GCS) score was 15/15 with no focal neurological deficit. The wound was clean and dry. She received cefazolin, dexamethasone, haloperidol (2.5 mg, IM, q6hr), metoclopramide (10 mg, q8hr), and phenytoin (100 mg, IV, q8hr). In the context of her clinical condition, vasculitis screening for antineutrophil cytoplasmic antibodies, antinuclear antibody, HIV test and CD4 count was requested. The results revealed reduced levels of IgG and IgM. Consultation with an immunologist suggested that the low immunoglobulin level could explain her underlying fungal infection. Seven days after surgery she showed decreased level of consciousness due to intracerebral hemorrhage at the biopsy site and sepsis caused by Gram-negative bacilli. She became febrile, tachycardic, and had leukocytosis (white blood cell \[WBC\] count, 12.34×10^9^/L). She was evaluated by the infectious diseases and ENT specialists. Her renal function tests showed high creatinine (150 µmol/L) and blood urea nitrogen levels. Because of her new symptoms, she underwent a second craniotomy which revealed subgaleal, left epidural and subdural and intraventricular abscesses that were evacuated and irrigated thoroughly. Pure pus drained after insertion of an external ventricular drain in the right frontal abscess. Specimens were collected during surgery and pus from abscesses and tissue samples were sent for culture and histopathology. Cerebrospinal fluid (CSF) analysis showed a red blood cell count of 50/mm3 and WBC 700×10^6^/L (90% polymorphs and 10% mononuclear cells). All cultures of specimens including blood, stool, CSF, brain abscess, and scalp wound yielded ampicillin and ciprofloxacin-resistant (MIC=0.094 µg/mL, Nalidixic Acid=R) group B *Salmonella* species. Intravenous (IV) ceftriaxone (2 g) 12-hourly was started. A brain CT scan showed purulent fluid, edema with subsequent mass effect on the frontal horn of the lateral ventricles and a small suspicious communication with the left frontal horn and abscess collection in the left lateral ventricle with mild enhancement of the ventricular outlines suggestive of ventriculitis (**[Figure 3](#F3){ref-type="fig"}**). The patient developed seizures triggered by sepsis and neuroleptics. Her clinical condition deteriorated over time due to *Salmonella* sepsis and ventriculitis, renal impairment, malnutrition, pancytopenia and high risk of aspiration pneumonia. She was intubated, drowsy (GCS: 11/15), moved all 4 limbs, grasped both hands on command, and had symmetric and reactive pupils. She exhibited convulsive movements of the left eyelids and right distal foot. Despite aggressive management, the patient died due to severe infection and respiratory arrest. A timeline table showing the progress of the patient since admission and throughout the hospitalization course is shown in (**[Table 1](#T1){ref-type="table"}**).

![Postoperative MRI-Brain. Complex signal abnormality noted at the surgical bed at bifrontal (**A**) and (**B**), region most likely representing subacute blood, some purulent fluid, pneumocephalus and edema with possible communication with the left lateral ventricle (**C**) and (**D**). No brain infarction or venous sinus thrombosis.](SaudiMedJ-39-935-g003){#F3}

###### 

A timeline table showing the progress of the patient since admission and throughout the hospitalization course.

![](SaudiMedJ-39-935-g004)

Discussion {#sec1-3}
==========

Invasive aspergillosis is a fatal infection that commonly affects immunocompromised hosts. Individuals at the highest risk of acquiring invasive aspergillosis include patients with leukemia during induction therapy; solid organ transplant, prolonged neutropenia, immunodeficiency, and corticosteroid use.[@ref1]-[@ref3] Invasive aspergillosis is rare in immunocompetent individuals.[@ref5]-[@ref7]

Although no clear association exists in the literature between SCD and invasive aspergillosis, SCD is suggested to have contributed to the pathogenesis of invasive aspergillosis in the present case. In addition, her underlying hematological disease combined with the incomplete sinus debridement, Intensive care unit admission, and surgical interventions triggered a complicated clinical course including intracerebral aspergilloma and Gram-negative *Salmonella* bacteremia. Additionally, multiple catheterization, abnormal renal function and mechanical ventilation might have adversely affected the immune function and led to the poor outcome.

The most frequent symptoms in patients with Central Nervous System (CNS) aspergillosis are headache, vomiting, convulsions, fever, and cranial nerve paralysis. Our patient presented mainly with prolonged headache and dizziness. This suggests that in SCD patients, such history should raise the clinical suspicion of possible fungal infection caused by *Aspergillus* species. In addition, environmental factors including airborne mold concentrations, geographic location, and constructional work may influence IA development.[@ref8]

An interesting magnetic resonance imaging finding in this case is the observation of irregularity and mild narrowing of the arteries of the circle of Willis, including the terminal internal carotid, proximal middle cerebral, anterior cerebral and posterior cerebral arteries due to the patient's SCD. We proposed that might be the reason for the rapid progression and invasiveness of the fungal infection in this case.

Voriconazole, isavuconazole and amphotericin B are the antifungal agents used for the first-line treatment of IA.[@ref9],[@ref10] Caspofungin have been shown to exert in vitro and in vivo activity against *Aspergillus* spp and is approved for the treatment of IA in patients who are intolerant to first-line therapy.[@ref9] Our patient was treated with voriconazole and caspofungin. Combination therapy with voriconazole and caspofungin in treatment of CNS aspergillosis is promosing.[@ref10] However, we believe that, the severity of infection, coinfection with *Salmonella* ventriculitis and sepsis contribute to the poor outcome in this patient.

In conclusion, invasive aspergillosis should be included in the differential diagnosis of SCD patients with CNS lesions, particularly if presented with chronic symptoms suggestive of CNS involvement. Rapid diagnosis and aggressive medical and surgical management are of the utmost importance.
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